MALVERN, Pa., Jan. 07, 2025 (GLOBE NEWSWIRE) -- via IBN – Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage ...

Alzheimer's disease is a disorder of the brain that results in cognitive decline and is the main cause of dementia. Two types of early-stage Alzheimer's disease drugs were in practical use in Japan as ...

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

Alzheimer’s disease primarily affects people over the age of 65, but it’s never too early to be aware of the warning signs of this common brain disorder. And you may be able to detect them ...